| Citation: |
ZHANG Yu, ZHANG Can, ZHANG Weiling. Mechanism of long non-coding RNA NR2F1-AS1 regulates proliferation and apoptosis of ovarian cancer cells by targeting microRNA-493-5p expression[J]. Journal of Clinical Medicine in Practice, 2023, 27(4): 30-34. DOI: 10.7619/jcmp.20222967
|
To explore the mechanism of long non-coding RNA NR2F1-AS1 (LncRNA NR2F1-AS1) in regulating proliferation and apoptosis of ovarian cancer cells by targeting microRNA-493-5p (miR-493-5p) expression.
The quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression levels of NR2F1-AS1 and miR-493-5p in different lines of ovarian cancer cells; the dual luciferase reporter gene was used to detect the interaction between NR2F1-AS1 and miR-493-5p; the MTT proliferation assay was used to determine the change in the proliferation ability of ovarian cancer cells after interference with NR2F1-AS1 expression or miR-493-5p overexpression; the apoptosis rate of ovarian cancer cells was detected by flow cytometry; the Western blot was used to detect the protein expression levels of CyclinD1, p21, p27, Bcl-2, Bax and cleaved-caspase 3.
Compared with normal ovarian epithelial cells, the expression level of NR2F1-AS1 in ovarian cancer cells increased significantly, while the expression level of miR-493-5p decreased significantly (P < 0.05). The dual luciferase assay confirmed that NR2F1-AS1 could specifically bind to miR-493-5p, and the expression and activity of miR-493-5p were negatively regulated by NR2F1-AS1. Interference with NR2F1-AS1 expression or overexpression of miR-493-5p could inhibit the proliferation of ovarian cancer cells, promote apoptosis, significantly up-regulate the expression of p21, Bax, p27 and cleaved-caspase 3, and down-regulate protein expression levels of CyclinD1 and Bcl-2. Inhibiting the expression of miR-493-5p was able to reverse the effect of interference with the expression of NR2F1-AS1 on the proliferation and apoptosis of ovarian cancer cells.
Interference with the expression of NR2F1-AS1 can inhibit the proliferation of ovarian cancer cells and induce apoptosis by up-regulating the expression of miR-493-5p.
| [1] |
张素仙, 聂小凤, 张琴, 等. 长链非编码RNA癌易感性候选基因2在卵巢癌中的表达及其对SKOV3细胞恶性表型的影响[J]. 实用医学杂志, 2019, 35(2): 191-195. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201902007.htm
|
| [2] |
WANG L, ZHAO S S, MINGXIN Y U. LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4[J]. Pharmazie, 2019, 74(5): 295-300.
|
| [3] |
HUANG H, CHEN J, DING C M, et al. LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363[J]. J Cell Mol Med, 2018, 22(6): 3238-3245. doi: 10.1111/jcmm.13605
|
| [4] |
GUO F, FU Q F, WANG Y, et al. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis[J]. J Cell Mol Med, 2019, 23(9): 5907-5919. doi: 10.1111/jcmm.14386
|
| [5] |
ZHANG Z Q, LUO G Z, YU C D, et al. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5[J]. J Cell Physiol, 2019, 234(8): 13525-13533. doi: 10.1002/jcp.28030
|
| [6] |
WANG G N, FANG X S, HAN M, et al. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2[J]. Int J Mol Med, 2018, 41(3): 1740-1748.
|
| [7] |
ZHAO L F, FENG X B, SONG X B, et al. MiR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4[J]. Oncol Rep, 2016, 36(2): 1007-1015. doi: 10.3892/or.2016.4882
|
| [8] |
建方方, 刘华, 冯炜炜, 等. CXCL5通过上调Cyclin D1促进卵巢癌细胞增殖[J]. 现代妇产科进展, 2018, 27(4): 255-258.
|
| [9] |
张晓君. LncRNA AC006449. 2抑制卵巢癌细胞增殖[J]. 中国生物化学与分子生物学报, 2019, 35(3): 310-315. https://www.cnki.com.cn/Article/CJFDTOTAL-SWHZ201903010.htm
|
| [10] |
韦唯, 葛葵葵, 徐宇强, 等. MicroRNA-493抑制乳腺癌MCF7细胞增殖、迁移和成瘤能力[J]. 中国细胞生物学学报, 2015, 37(4): 486-492. https://www.cnki.com.cn/Article/CJFDTOTAL-XBZZ201504005.htm
|
| [11] |
LIANG Z, KONG R, HE Z, et al. High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1[J]. Oncotarget, 2017, 8(29): 47389-47399. doi: 10.18632/oncotarget.17650
|
| [12] |
WANG S, WANG X, LI J F, et al. C-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer[J]. Oncotarget, 2017, 8(47): 82303-82313. doi: 10.18632/oncotarget.19398
|
| [13] |
ZHAO J L, XU T S, WANG F, et al. MiR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73[J]. Biomedecine Pharmacother, 2017, 90: 744-751.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: